Human Mixtard 50 Injection

Composition of Human Mixtard 50 Injection

Human Mixtard 50 Injection contains Human Insulin (40IU/ml). It belongs to the Insulin (premixed human insulin: regular + NPH) class of medicines.

Uses of Human Mixtard 50 Injection

Treatment of diabetes mellitus (type 1 and type 2) requiring insulin to control blood glucose levels

Key benefits

• Controls fasting and post-meal blood sugar
• Provides both rapid and intermediate insulin coverage
• Helps reduce diabetes-related complications with good control
• Convenient premixed insulin regimen

How Human Mixtard 50 Injection works

This is a premixed insulin containing short-acting regular insulin for mealtime glucose control and intermediate-acting NPH insulin for longer basal control. It lowers blood glucose by increasing glucose uptake in muscle and fat and reducing glucose production by the liver.

How to take Human Mixtard 50 Injection

For subcutaneous injection only, as prescribed by the doctor. Usually injected 30 minutes before meals; dosing and timing are individualized based on blood glucose. Rotate injection sites (abdomen, thigh, upper arm); do not massage the site. Do not use if the suspension is not uniformly milky after gentle rolling.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Contact your doctor or diabetes nurse for advice — do not take a double dose to make up for a missed injection.

If you take too much

An overdose of this medicine can cause severe low blood sugar, leading to fits or unconsciousness — this is a medical emergency. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Human Mixtard 50 Injection

Most side effects of Human Mixtard are mild and settle as the body adjusts. Reported side effects include:

• Hypoglycaemia (low blood sugar)
• injection site reactions (pain
• redness
• swelling)
• weight gain
• lipodystrophy (lumps or dents at injection site)
• oedema
• allergic reactions (rash
• itching)

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Human Mixtard 50 Injection

Warnings and precautions

Risk of hypoglycaemia—carry glucose/sugar and monitor blood glucose regularly. Do not use during episodes of hypoglycaemia. Dose adjustments may be needed with changes in diet, activity, illness, stress, kidney or liver disease. Use caution while driving/operating machinery if prone to low sugar. Injection must be subcutaneous; avoid intravenous use. Rotate sites to reduce lipodystrophy. Seek urgent help for severe allergy or severe hypoglycaemia.

Do not take Human Mixtard if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not to be used during an episode of low blood sugar.

Interactions with other medicines

Other antidiabetics,ACE inhibitors (e.g., enalapril),beta-blockers (may mask hypoglycaemia),corticosteroids (e.g., prednisolone),thiazide diuretics,thyroid hormones,sympathomimetics (e.g., salbutamol),MAO inhibitors,alcohol

How to store Human Mixtard 50 Injection

Store refrigerated at 2–8°C; do not freeze. Protect from light. After opening/in-use, store as per label instructions (often below 25–30°C) and use within the recommended period; keep away from heat and direct sunlight.

Expert advice for Human Mixtard 50 Injection

Keep an unopened supply in the fridge and the pen in use at room temperature, away from direct sunlight. Always carry a fast-acting sugar source. Check your sugar as your doctor has instructed, and keep a record to take to appointments.

Manufacturer and class

Manufacturer:

ABBOTT INDIA LTD

Therapeutic class:

Antidiabetic

Drug class:

Insulin (premixed human insulin: regular + NPH)